Drugs / CSTC1
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01813305 Comparator | Jul 2014 → Jan 2020 | diabetes mellitus, ulcer of lower limbs | Charsire Biotechnology Corp. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CSTC1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01813305 ↗ |
| Route | Topical | “topical application on target diabetic foot ulcer (DFU)” NCT01813305 ↗ |